Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yue Ping

Showing results (591-600 of 671) with videos related to

Pageof 68
Sort By:
Scientific Reports|October 20, 2024
Dosimetric benefit and clinical feasibility of deep inspiration breath-hold and volumetric modulated arc therapy-based postmastectomy radiotherapy for left-sided breast cancerShi-Jia Wang, Yi-Rui Zhai, Wen-Wen Zhang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 6, 2015
Survival benefit with IMRT following narrow-margin hepatectomy in patients with hepatocellular carcinoma close to major vesselsWei-Hu Wang, Zhi Wang, Jian-Xiong Wu, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2025
Discovery of DC20 as a potential non-nucleoside reverse transcriptase inhibitor with excellent pharmacokinetic propertiesJia-Yu Liu, Meng-Di Ma, Yi-Ming Li, et al.
Blood|July 25, 2012
Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapyZhao-Yang Wang, Qing-Feng Liu, Hua Wang, et al.
British Journal of Cancer|March 25, 2023
The prognostic value of tumour-infiltrating lymphocytes, programmed cell death protein-1 and programmed cell death ligand-1 in Stage I-III triple-negative breast cancerGuang-Yi Sun, Jing Zhang, Bing-Zhi Wang, et al.
Medicine|May 27, 2016
Efficacy and Safety of Intensity-Modulated Radiotherapy Following Transarterial Chemoembolization in Patients With Unresectable Hepatocellular CarcinomaTao Zhang, Yu-Ting Zhao, Zhi Wang, et al.
Oncotarget|March 26, 2016
Interim analysis of postoperative chemoradiotherapy with capecitabine and oxaliplatin versus capecitabine alone for pathological stage II and III rectal cancer: a randomized multicenter phase III trialYan-Ru Feng, Yuan Zhu, Lu-Ying Liu, et al.
Leukemia & Lymphoma|November 1, 2011
The extent of cutaneous lesions predicts outcome in extranodal nasal-type natural killer/T-cell lymphoma of the upper aerodigestive tract with secondary cutaneous involvementShu-Nan Qi, Ye-Xiong Li, Wei-Hu Wang, et al.
Cell Research|September 26, 2007
Rig-I-/- mice develop colitis associated with downregulation of G alpha i2Yi Wang, Hong-Xin Zhang, Yue-Ping Sun, et al.
Bioorganic Chemistry|November 2, 2025
Discovery of 2-aryl-1H-pyrazole-S-DACO analogs as novel inhibitors targeting the DENV NS5 proteinJia-Yu Liu, Jian-Xia Xue, Wen-Kai Pan, et al.
Pageof 68

Showing results (591-600 of 671) with videos related to

Sort By:
Pageof 68
Scientific Reports|October 20, 2024
Dosimetric benefit and clinical feasibility of deep inspiration breath-hold and volumetric modulated arc therapy-based postmastectomy radiotherapy for left-sided breast cancerShi-Jia Wang, Yi-Rui Zhai, Wen-Wen Zhang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 6, 2015
Survival benefit with IMRT following narrow-margin hepatectomy in patients with hepatocellular carcinoma close to major vesselsWei-Hu Wang, Zhi Wang, Jian-Xiong Wu, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2025
Discovery of DC20 as a potential non-nucleoside reverse transcriptase inhibitor with excellent pharmacokinetic propertiesJia-Yu Liu, Meng-Di Ma, Yi-Ming Li, et al.
Blood|July 25, 2012
Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapyZhao-Yang Wang, Qing-Feng Liu, Hua Wang, et al.
British Journal of Cancer|March 25, 2023
The prognostic value of tumour-infiltrating lymphocytes, programmed cell death protein-1 and programmed cell death ligand-1 in Stage I-III triple-negative breast cancerGuang-Yi Sun, Jing Zhang, Bing-Zhi Wang, et al.
Medicine|May 27, 2016
Efficacy and Safety of Intensity-Modulated Radiotherapy Following Transarterial Chemoembolization in Patients With Unresectable Hepatocellular CarcinomaTao Zhang, Yu-Ting Zhao, Zhi Wang, et al.
Oncotarget|March 26, 2016
Interim analysis of postoperative chemoradiotherapy with capecitabine and oxaliplatin versus capecitabine alone for pathological stage II and III rectal cancer: a randomized multicenter phase III trialYan-Ru Feng, Yuan Zhu, Lu-Ying Liu, et al.
Leukemia & Lymphoma|November 1, 2011
The extent of cutaneous lesions predicts outcome in extranodal nasal-type natural killer/T-cell lymphoma of the upper aerodigestive tract with secondary cutaneous involvementShu-Nan Qi, Ye-Xiong Li, Wei-Hu Wang, et al.
Cell Research|September 26, 2007
Rig-I-/- mice develop colitis associated with downregulation of G alpha i2Yi Wang, Hong-Xin Zhang, Yue-Ping Sun, et al.
Bioorganic Chemistry|November 2, 2025
Discovery of 2-aryl-1H-pyrazole-S-DACO analogs as novel inhibitors targeting the DENV NS5 proteinJia-Yu Liu, Jian-Xia Xue, Wen-Kai Pan, et al.
Pageof 68